TRANSACTION REPORT · SEC DISCLOSURES
Deal notes
ContextDeal context
This is an ATM facility event. The capacity shown is not cash raised.
Gross proceedsNo cash proceeds
Offering price—
Discount to prior close—
Warrant coverage—
Sales agentH.C. Wainwright & Co.
Transaction overview
01Virax Biolabs Group Ltd disclosed an at-the-market program event: facility amended. Available capacity is $2.1M. This event does not record cash proceeds raised.
- Financing type
- ATM
- Announcement date
- —
- SEC disclosure date
- Sep 4, 2026
- Agreement date
- Jan 22, 2024
- Pricing date
- —
- Closing date
- —
- Filing date
- Sep 4, 2026
- Status
- Amended
- Market cap before SEC disclosure
- $1.0M
- Prior closing price
- $2.56
- Raise as % of market cap
- —
Market data · FMP
- Historical market cap
- $1,017,830.4
- Market date
- Sep 3, 2026
- Closing price
- $2.56
- Latest reported shares outstanding
- 19,923,431
- Latest reported float shares
- 19,566,104
- Share-data date
- Oct 1, 2026
Market cap and closing price are from FMP for the date shown. Shares are FMP’s latest available snapshot, dated separately. Updated Oct 1, 2026.
Financial Modeling Prep ↗Financing terms
02At-the-market program
- Capital event
- Facility amended
- Available capacity
- $2.1M
- Proceeds raised
- Not reported as raised
- Shares sold
- —
- Average sale price
- —
- Relevant period
- Not applicable
- Sales commission
- —
Fees & transaction economics
03- Placement agent / underwriting fee
- —
- Agent fee amount
- —
- Management fee
- —
- Other offering expenses (estimated)
- —
- Net proceeds (estimated)
- —
- Net proceeds as % of gross
- —
Fee amounts reflect disclosed inputs. Unknown expense components are not assumed to be zero.
Transaction participants
04IssuerVirax Biolabs Group LtdIssuer
Investor names: —
Source documents
05SEC filings, exhibits and attributed market data. The report separates disclosed facts, calculated metrics, and unknown terms.
424B5 · Virax Biolabs Group LtdSEC filing · Sep 4, 2026
Open source ↗FMP historical market data · VRAXMarket data · Sep 3, 2026
Open source ↗Filing evidence & original calculations
SEC disclosure date
2026-09-04
424B5 Filed pursuant to Rule 424(b)(5) Registration No. 333-275893 PROSPECTUS SUPPLEMENT (to Prospectus Supplement datedOriginal source ↗
date Basis
sec_disclosure
424B5 Filed pursuant to Rule 424(b)(5) Registration No. 333-275893 PROSPECTUS SUPPLEMENT (to Prospectus Supplement datedOriginal source ↗
atm Event
Facility amended
update the maximum amount of our ordinary shares we are eligible to sellOriginal source ↗
atm Capacity Basis
Available capacity
having an aggregate offering price of up to $2,070,060.20Original source ↗
agreement Date
2024-01-22
dated January 22, 2024, by and between us and H.C. Wainwright & Co., LLCOriginal source ↗
status
Amended
update the maximum amount of our ordinary shares we are eligible to sellOriginal source ↗
market Cap
FMP reported market cap; as of 2026-09-03.
{"provider": "FMP", "symbol": "VRAX", "date": "2026-09-03", "marketCap": 1017830.4}Original source ↗